Results 121 to 130 of about 6,088 (246)
Immunotherapy has shown limited efficacy in colorectal cancer (CRC), necessitating the urgent identification of novel immunotherapeutic targets to address this challenge.
Nan-Nan Dai +5 more
doaj +1 more source
Background The tumor immune microenvironment, including neutrophils and tertiary lymphoid structures (TLSs), is pivotal for HCC prognosis assessment. Tumor‐associated neutrophils exhibit plasticity, adopting either an antitumorigenic N1 (MPO+ CD206−) or ...
Yanfei Lang +6 more
doaj +1 more source
Sustained innate interferon is an essential inducer of tertiary lymphoid structures [PDF]
Tertiary lymphoid structures (TLS) resemble follicles of secondary lymphoid organs and develop in nonlymphoid tissues during inflammation and cancer. Which cell types and signals drive the development of TLS is largely unknown.
Calvanese, Anna Laura +11 more
core +1 more source
Assessment of tertiary lymphoid structures in salivary glands, pancreas, and lungs of NZB/W lupus prone mice. [PDF]
Autoimmune diseases are complex genetic traits. Factors that trigger autoimmune diseases have yet to be deciphered. It is however suspected that a combination of copious risk factors is implicated in the development of autoimmunity.
Miancho, Diana Roza Kibancha
core
ObjectiveTo explore the impact of tertiary lymphoid structure (TLS) on the efficacy of adjuvant transcatheter arterial chemoembolization (TACE) following curative resection in patients with hepatocellular carcinoma (HCC).
Fansheng MENG, Haokang YANG, Biwei YANG
doaj +1 more source
Both anaplastic thyroid cancer (ATC) and papillary thyroid cancer (PTC) originate from thyroid follicular epithelial cells, but ATC has a significantly worse prognosis and shows resistance to conventional therapies.
Pei-Zhen Han +14 more
doaj +1 more source
BackgroundSubstantial studies reveal that tertiary lymphoid structure (TLS) correlate with prognosis and immunotherapy response in various types of cancers.
Fan Wu +31 more
doaj +1 more source
Tertiary Lymphoid Structures Are Associated with Favorable Clinical Outcomes and Negatively Correlated with Cancer-Associated Fibroblasts in Esophageal Cancer [PDF]
Background: Esophageal cancer remains a highly aggressive malignant tumor with poor prognosis, despite advances in combination therapies and novel immunotherapies.
Akai, Masaaki +15 more
core +1 more source
IL-36 gamma promotes anti-tumor immunity through therapeutic induction of tumor-associated tertiary lymphoid structures [PDF]
The last decade has advanced our understanding of the composition of the tumor-immune microenvironment and its role as a potential target for therapeutic intervention.
Weinstein, Aliyah M
core
HLA class II neoantigen presentation for CD4+ T cell surveillance in HLA class II-negative colorectal cancer [PDF]
札幌医科大学博士(医学)doctoral ...
松本, 哲
core +2 more sources

